Dow Up 1.31% Nasdaq Up 2.40%

More On IMU.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Imugene Ltd. (IMU.AX)

-ASX
0.01 Down 0.00(16.67%) 1:10AM EDT
Prev Close:0.01
Open:0.01
Bid:0.01
Ask:0.01
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.01 - 0.01
52wk Range:0.01 - 0.03
Volume:872,035
Avg Vol (3m):720,282
Market Cap:9.47M
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.10
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Imugene Limited, an immuno-oncology biopharmaceutical company, together with its subsidiaries, engages in the research and development of novel antisense pharmaceuticals in Australia. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback